BUZZ-Pfizer shares up ahead of co analyst and investor call Tuesday

Reuters12-16 04:52
BUZZ-Pfizer shares up ahead of co analyst and investor call Tuesday

** Shares of Pfizer PFE.N are up 2.9% on Mon ahead of the co's analyst and investor call Tuesday to review full-year 2026 financial guidance

** Analysts expecting Q1 2026 EPS of 77 cents and FY 2026 EPS of $3.05, per LSEG data

** Stock is helping to support the S&P 500 healthcare index .SPXHC, which is leading sector gains for the benchmark S&P 500 .SPX with gain of more than 1% on the session

** Bloomberg News reported last week, citing people familiar with the matter, Pfizer will cut over 200 jobs in Switzerland as part of its multi-year cost reduction program

** Also last week, Pfizer said it was partnering with YaoPharma, a subsidiary of China's Shanghai Fosun Pharmaceutical 600196.SS to develop and commercialize an experimental weight-management treatment

** In November, Pfizer lifted its full-year profit forecast for the second time in a row, helped by strong demand for its blockbuster heart treatment and blood thinner

** Shares of Pfizer are nearly flat YTD, compared with a roughly 16% gain in the S&P 500 .SPX

(Reporting by Caroline Valetkevitch)

((caroline.valetkevitch@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment